Pharmaceutical computational chemists leverage advanced computational techniques and molecular modeling tools to accelerate drug discovery and development. By simulating molecular interactions, predicting chemical properties, and designing novel compounds, they help identify promising drug candidates before costly laboratory synthesis and testing. These scientists use methods such as molecular docking, quantum mechanics, and molecular dynamics to understand the behavior of drug molecules and their targets at the atomic level. Their work significantly reduces the time and cost associated with bringing new medications to market, improving efficiency in pharmaceutical research.
Pharmaceutical computational chemists analyze the pharmacokinetics and toxicity profiles of compounds using in silico models, helping to predict how drugs will behave in the human body. They collaborate closely with medicinal chemists, biologists, and pharmacologists to optimize drug candidates and guide experimental efforts. As artificial intelligence and machine learning technologies advance, computational chemists increasingly integrate these tools to enhance predictive accuracy and streamline drug development pipelines. Their expertise is crucial in bridging theoretical chemistry and practical application, driving innovation and improving the success rate of new therapeutic agents. Their contributions are pivotal in shaping the future of personalized medicine and targeted therapies. Furthermore, their work supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia